Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brefel

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Revue Neurologique|June 22, 2021
Body mass index variations in patients with Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion: A case control study versus standard of care and subthalamic nucleus deep brain stimulationB Fernández-Rodríguez, J Dupouy, E Harroch, et al.
Neurology|September 30, 2010
Motor activation in multiple system atrophy and Parkinson disease: a PET studyP Payoux, C Brefel-Courbon, F Ory-Magne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's diseaseO Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Journal of Neuropathology and Experimental Neurology|April 22, 2004
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide geneR Vidal, B Ghetti, M Takao, et al.
Revue Neurologique|August 26, 2023
Impact of therapeutic education on the evolution of social representations of medication in patients with Parkinson's disease: A quantitative and qualitative study (ETPARK REMED)I Faurie, E Harroch, C Scotto d'Apollonia, et al.
Revue Neurologique|May 17, 2024
French guidelines for the diagnosis and management of Tourette syndromeA Hartmann, S Ansquer, C Brefel-Courbon, et al.
Journal of Medical Genetics|April 10, 2009
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's diseaseS Lesage, C Condroyer, A Lannuzel, et al.
American Journal of Human Genetics|February 17, 2001
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effectsM Periquet, C Lücking, J Vaughan, et al.
Revue Neurologique|September 27, 2021
Validation of a non-motor fluctuations questionnaire in Parkinson's diseaseF Faggianelli, A Loundou, K Baumstarck, et al.
Human Molecular Genetics|March 11, 1999
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's DiseaseN Abbas, C B Lücking, S Ricard, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Revue Neurologique|June 22, 2021
Body mass index variations in patients with Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion: A case control study versus standard of care and subthalamic nucleus deep brain stimulationB Fernández-Rodríguez, J Dupouy, E Harroch, et al.
Neurology|September 30, 2010
Motor activation in multiple system atrophy and Parkinson disease: a PET studyP Payoux, C Brefel-Courbon, F Ory-Magne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 2, 2001
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's diseaseO Rascol, I Arnulf, H Peyro-Saint Paul, et al.
Journal of Neuropathology and Experimental Neurology|April 22, 2004
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide geneR Vidal, B Ghetti, M Takao, et al.
Revue Neurologique|August 26, 2023
Impact of therapeutic education on the evolution of social representations of medication in patients with Parkinson's disease: A quantitative and qualitative study (ETPARK REMED)I Faurie, E Harroch, C Scotto d'Apollonia, et al.
Revue Neurologique|May 17, 2024
French guidelines for the diagnosis and management of Tourette syndromeA Hartmann, S Ansquer, C Brefel-Courbon, et al.
Journal of Medical Genetics|April 10, 2009
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's diseaseS Lesage, C Condroyer, A Lannuzel, et al.
American Journal of Human Genetics|February 17, 2001
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effectsM Periquet, C Lücking, J Vaughan, et al.
Revue Neurologique|September 27, 2021
Validation of a non-motor fluctuations questionnaire in Parkinson's diseaseF Faggianelli, A Loundou, K Baumstarck, et al.
Human Molecular Genetics|March 11, 1999
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's DiseaseN Abbas, C B Lücking, S Ricard, et al.
Pageof 7